Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

NCT01367275 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Sponsor closed study

Conditions

Colorectal Cancer
Colorectal Adenocarcinoma

Interventions

DRUG: Brivanib
DRUG: Irinotecan

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]